Introducing Bactorinol® Nasal Spray: A New, Versatile Format to Maximize the Power of Winterized Lentisk Oil!
Bactorinol®, available as nasal drops since 2021 in Italy, has gained international interest and is now available in a convenient spray format.
Formulated with Winterized Lentisk Oil (WLO) from Pistacia lentiscus berries, it has been clinically proven to reduce biofilm formation and alleviate Chronic RhinoSinusitis (CRS) symptoms, with recent studies confirming significant improvements in both biofilm presence and overall symptom relief.
Discover the New Bactorinol® Nasal Spray for Your Portfolio!
We’re excited to introduce the new Bactorinol® Nasal Spray, offering a more versatile and user-friendly way to deliver the benefits of Bactorinol®. Specifically designed for adults, the spray format provides easier, more precise application compared to traditional drops. Whether at home or on the go, the spray is ideal for effectively managing rhinosinusitis symptoms.
Expand Your ENT Product Line: Drops and Spray Formats
Now, you can strengthen your ENT product offering with both Bactorinol® Nasal Drops and the new Bactorinol® Nasal Spray. Both formats feature the same potent formulation with Winterized Lentisk Oil (WLO), giving healthcare providers more flexibility to meet diverse patient needs.
Why Bactorinol® Nasal Spray is a Strategic Addition
Bactorinol® is recognized for its clinically proven efficacy in treating acute recurrent rhinosinusitis. With the new spray format, it offers even greater convenience and appeal, making it an excellent addition to your product portfolio.
Key Advantages:
- Anti-inflammatory & Decongestant: Relieves facial pain and congestion.
- Antibacterial Action: Reduces pathogenic bacteria.
- Biofilm Disruption: Breaks down bacterial biofilms, reducing infection recurrence.
- Mucus Clearance: Improves mucociliary function and softens nasal mucosa for better mucus removal.
Backed by Clinical Results
A clinical study with 100 chronic rhinosinusitis patients showed that Bactorinol® delivers:
- 39% reduction in symptoms like pain and congestion.
- 67% decrease in patients showing biofilm presence.
- Enhanced nasal airflow and mucociliary function, improving quality of life.
Bactorinol® Nasal Spray: The Smart Choice for Business Growth
The new spray format complements the established success of Bactorinol® Nasal Drops, providing more opportunities to expand your market share in ENT solutions.
Bactorinol® Nasal Drops was also a finalist in the 2023 NutraIngredients Awards in the Botanical category—further proof of the product’s innovation and efficacy.
Take advantage of this opportunity to grow your business with Bactorinol® Nasal Spray, a product that meets both patient and market demands.
